help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on July 10, 2003, doi:10.1165/rcmb.2003-0102OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-0102OCv1
30/1/38    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banerjee, S. K.
Right arrow Articles by Blackburn, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banerjee, S. K.
Right arrow Articles by Blackburn, M. R.
American Journal of Respiratory Cell and Molecular Biology. Vol. 30, pp. 38-50, 2004
© 2004 American Thoracic Society
DOI: 10.1165/rcmb.2003-0102OC

Abnormal Alveolar Development Associated with Elevated Adenine Nucleosides

Suman K. Banerjee, Hays W. J. Young, Andrea Barczak, David J. Erle and Michael R. Blackburn

Department of Biochemistry and Molecular Biology, University of Texas, Houston Medical School, Houston, Texas; and Department of Medicine, University of California, San Francisco, California

Address correspondence to: Dr. Michael R. Blackburn, Department of Biochemistry and Molecular Biology, University of Texas-Houston Medical School, 6431 Fannin, Houston, TX 77030. E-mail: Michael.R.Blackburn{at}uth.tmc.edu

Adenosine signaling has been characterized in various physiologic systems, but little is known about the role of adenosine signaling in lung development. Alveogenesis and microvascular maturation are the final stages in lung development in mammals. Alveogenesis in the mouse begins on Postnatal Day 5, when the process of secondary septation plays a pivotal role in the expansion of the alveolar sacs and microvascular maturation. Adenosine deaminase null mice (ADA-/-) exhibit abnormalities in alveogenesis in association with elevated lung adenosine levels. Large-scale gene expression analysis of ADA-/- lungs using oligonucleotide-based microarrays revealed novel relationships between gene expression patterns and elevated lung adenosine during the stages of alveolar maturation. Genes regulating apoptosis, proliferation, and vascular development were shown to be altered, and decreased cell proliferation in association with increased alveolar type II cell apoptosis was shown to contribute to abnormal secondary septation in these mice. ADA enzyme therapy allowed for normal patterns of apoptosis, proliferation, and alveolar development in association with prevention of adenosine elevations. These findings were correlated with the presence of adenosine receptors in the developing lung, suggesting the involvement of receptor signaling. These studies provide evidence that elevated lung adenosine can lead to abnormal alveogenesis by disrupting patterns of cell proliferation and apoptosis.

Abbreviations: adenosine deaminase–deficient, ADA-/- • bronchopulmonary dysplasia, BPD • bromodeoxyuridine, BrdU • complementary deoxyribonucleic acid, cDNA • immunohistochemistry, IHC • kinase insert domain protein receptor, KDR • polyethylene glycol modified-ADA, PEG-ADA • reverse transcription polymerase chain reaction, RT-PCR • sodium hydroxide, NAOH • significant analysis of microarrays, SAM • sodium dodecyl sulfate, SDS • surfactant proteins, SP • tissue transglutaminases, Ttg • terminal transferase-mediated dUTP nick end labeling, TUNEL • vascular endothelial growth factor D, VEGF-D







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2004 American Thoracic Society.
  SOTA, FL